Browsing by Author Mettananda, S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 50 to 69 of 132 < previous   next >
Issue DateTitleAuthor(s)
2019Familial glucocorticoid deficiency presenting with hyperpigmentation, gigantism, and motor development delay: a case report.Uyangoda, K.; Kamalanathan, P.; Mettananda, S.
2022Feeding practices of neonates admitted to the neonatal intensive care unit of colombo north teaching hospital, Sri LankaSuriapperuma, T.; Mettananda, S.
2024GDF15 linked to maternal risk of nausea and vomiting during pregnancyFejzo, M.; Rocha, N.; Cimino, I.; Lockhart, S.M.; Petry, C.J.; Kay, R.G.; Burling, K.; Barker, P.; George, A.L.; Yasara, N.; Premawardhena, A.; Gong, S.; Cook, E.; Rimmington, D.; Rainbow, K.; Withers, D.J.; Cortessis, V.; Mullin, P.M.; MacGibbon, K.W.; Jin, E.; Kam, A.; Campbell, A.; Polasek, O.; Tzoneva, G.; Gribble, F.M.; Yeo, G.S.H.; Lam, B.Y.H.; Saudek, V.; Hughes, I.A.; Ong, K.K.; Perry, J.R.B.; Sutton, C.A.; Baumgarten, M.; Welsh, P.; Sattar, N.; Smith, G.C.S.; Charnock- Jones, D.S.; Coll, A.P.; Meek, C.L.; Mettananda, S.; Hayward, C.; Mancuso, N.; O'Rahilly, S.
2024GDF15 molecule is responsible for low body mass index in children with thalassaemiaMettananda, S.
2021Genetic and epigenetic therapies for β-Thalassaemia by altering the expression of α-globin geneMettananda, S.
2020Genetic modifiers of β-thalassemia and their therapeutic implicationsYasara, Y.W.N.; Mettananda, S.
2019Genome editing of haemopoietic stem cells for treatment of thalassaemiaBadat, M.; Mettananda, S.; Hua, P.; Schwessinger, R.; Hughes, J.; Higgs, D.; Davies, J.
2022GrowthDissanayake, P.; Mettananda, S.
2014Growth parameters of Sri Lankan children during infancy: A comparison with world health organization Multicentre growth reference studyPerera, P.J.; Fernanado, M.P.; Ranathunga, N.; Sampath, W.; Samaranayake, R.; Mettananda, S.
2020A Guide to Paediatric Red Blood Cell DisordersMettananda, S.; Songdej, D.; Suriapperuma, T.
2019Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study.Mettananda, S.; Pathiraja, H.; Peiris, R.; Bandara, D.; de Silva, U.; Mettananda, C.; Premawardhena, A.
2022HematologyMettananda, S.; Williams, S.
2023Hemitruncus arteriosus: A rare congenital cardiac anomaly diagnosed and treated during the neonatal periodPathiraja, H.; de Livera, R.; Wickramaratne, S.; Perera, S.; Mugunthan, M.S.; Mettananda, S.
2023Hepatic and renal status of paediatric patients with thalassaemiaWijenayake, W.; Pathiraja, H.; Thennakoon, R.; Fernando, M.; Bandara, D.; Mettananda, S.
2021Hydroxyurea for transfusion dependent β-thalassaemia: A randomized double-blind placebo-controlled clinical trialYasara, N.; Wickramarathne, N.; Silva, I.; Hameed, N.; Attanayaka, A.M.K.R.; Jayasinghe, V.L.; Gunathilaka, P.A.C.K.; Wickramasinghe, N.; Rodrigo, R.; Perera, L; Perera, P.S.; Mettananda, K.C.D.; Manamperi, A.; Premawardhena, A.; Mettananda, S.
2022Hydroxyurea reduces the blood transfusion burden in patients with thalassaemia.Mettananda, S.
2023Hypopharyngeal foreign body impaction presenting late as acute onset torticollis due to retropharyngeal abscess formation in a childSooreakumar, A.; Dissanayake, D.M.D.T.; Wijenayake, W.; Bandara, P.K.B.U.C.; Dayasiri, K.; Mettananda, S.
2019Identifying haemoglobinopathy traits and iron deficiency in Sri Lanka using the dtchlorophenolindophenol (DCIP) and one- tube osmotic fragility (OF) tests and measurement of red cell zinc protoporphyrin (ZPP)Perera, P. S.; Premawardhena, A.; Mettananda, S.; Rodrigo, R.; Perera, L.; Weatherall, D. J.; Allen, S.; Allen, A.
2022Impact of covid-19 on the education and health of schooling children in Sri Lanka; A multi-provincial studyDayasiri, K.; Thadchanamoorthy, V.; kankananarachchi, I.; Umasankar, N.; Dassanayake, S.; Gunasekara, S.; Mettananda, S.
2020Improving standards of care for children with thalassaemia in Sri LankaMettananda, S.